The Bleeding Disorders Treatment Market Size was valued at USD 16.35 billion in 2023 and is projecte
The Bleeding Disorders Treatment Market is growing enormously because of the increasing incidence of bleeding disorders such as hemophilia, Von Willebrand disease (vWD), and other rare clotting disorders. Hemophilia, primarily Hemophilia A and B, is the most common, with an estimated incidence of about 1 in 5,000 male births worldwide. This has driven the demand for advanced therapies to improve the quality of life of patients and decrease the risks associated with bleeding events.